Mark J. Fitzpatrick's Net Worth
-$50 Thousand
Who is Mark J. Fitzpatrick?
Mark J. Fitzpatrick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allena Pharmaceuticals, Inc., CHIASMA, INC, and Aegerion Pharmaceuticals, Inc..
SEC CIK
Mark J. Fitzpatrick's CIK is 0001520265
Past Insider Trading and Trends
2018 was Mark J. Fitzpatrick's most active year for acquiring shares with 3 total transactions. Mark J. Fitzpatrick's most active month to acquire stocks was the month of January. 2020 was Mark J. Fitzpatrick's most active year for disposing of shares, totalling 1 transactions. Mark J. Fitzpatrick's most active month to dispose stocks was the month of November. 2020 saw Mark J. Fitzpatrick paying a total of $26,000.00 for 160,000 shares, this is the most they've acquired in one year. In 2020 Mark J. Fitzpatrick cashed out on 10,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allena Pharmaceuticals, Inc. (ALNAQ) Snapshot price: $0.0065
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIASMA, INC No price found
PresidentMark J. Fitzpatrick owns 19,612 units of Common Stock. From 2015 to 2020 Mark J. Fitzpatrick acquired a total of 19,612 shares in CHIASMA, INC at a cost of $50,030.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.04% | 10K |
$2.60 | $26,000.00 | 19.61K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
∞
| 9.61K |
$2.50 | $24,030.00 | 9.61K |
Scheduled
|
Dec 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||